(Q47977198)

7 February 2018

title

Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67. (English)

1 reference

7 February 2018

0 references

1 reference

9

Hironobu Sasano

1 reference

7 February 2018

Yasuhiro Miki

5

Yasuhiro Miki

1 reference

7 February 2018

Takashi Suzuki

2

Takashi Suzuki

1 reference

7 February 2018

Takanori Ishida

8

Takanori Ishida

1 reference

7 February 2018

Noriaki Ohuchi

10

Noriaki Ohuchi

1 reference

7 February 2018

Kiyoshi Takagi

4

Kiyoshi Takagi

1 reference

7 February 2018

Mika Watanabe

7

Mika Watanabe

1 reference

7 February 2018

Kentaro Tamaki

6

Kentaro Tamaki

1 reference

7 February 2018

author name string

Akiko Sato-Tadano

1

1 reference

7 February 2018

Masakazu Amari

3

1 reference

7 February 2018

publication date

21 August 2013

1 reference

7 February 2018

published in

Cancer Science

1 reference

7 February 2018

volume

104

1 reference

7 February 2018

issue

10

1 reference

7 February 2018

page(s)

1380-1388

1 reference

7 February 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

cites work

1 reference

Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years

21 January 2018

1 reference

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

21 January 2018

1 reference

Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression

21 January 2018

1 reference

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

21 January 2018

1 reference

Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity

21 January 2018

1 reference

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway

21 January 2018

1 reference

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

Emerging metabolic targets in cancer therapy

21 January 2018

1 reference

Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

21 January 2018

1 reference

Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.

21 January 2018

1 reference

Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival

21 January 2018

1 reference

Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.

21 January 2018

1 reference

Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase

21 January 2018

1 reference

Expression of hexokinase II and Glut-1 in untreated human breast cancer

21 January 2018

1 reference

Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis

21 January 2018

1 reference

Nucleobindin 2 in human breast carcinoma as a potent prognostic factor

21 January 2018

1 reference

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

Analysis of clinically relevant values of Ki-67 labeling index in Japanese breast cancer patients.

21 January 2018

1 reference

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

21 January 2018

1 reference

Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.

21 January 2018

1 reference

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

21 January 2018

1 reference

Expression of kinase genes in primary hyperparathyroidism: adenoma versus hyperplastic parathyroid tissue

21 January 2018

1 reference

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

Prognostic value of proliferation in invasive breast cancer: a review

21 January 2018

1 reference

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers

21 January 2018

1 reference

Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study

21 January 2018

1 reference

Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer

21 January 2018

1 reference

The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?

21 January 2018

1 reference

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

21 January 2018

1 reference

Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning

21 January 2018

1 reference

Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

21 January 2018

1 reference

Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway.

21 January 2018

1 reference

Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance.

21 January 2018

1 reference

Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.

21 January 2018

1 reference

PPARγ contributes to PKM2 and HK2 expression in fatty liver

21 January 2018

1 reference

miR-143 regulates hexokinase 2 expression in cancer cells

21 January 2018

1 reference

Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis

21 January 2018

1 reference

Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate

21 January 2018

1 reference

Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways

21 January 2018

1 reference

Lymph node micrometastases from breast carcinoma: reviewing the dilemma

21 January 2018

1 reference

Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.

21 January 2018

1 reference

12 December 2020

Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

1 reference

12 December 2020

Immunohistochemical assessment of hormone receptor status using a new scoring system (J-Score) in breast cancer

1 reference

12 December 2020

Mammalian hexokinases and their abnormal expression in cancer

1 reference

12 December 2020

Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12238

1 reference

7 February 2018

PMC publication ID

7656546

0 references

1 reference

7 February 2018